Long-lasting improvement following (-)-OSU6162 in a patient with Huntington's disease.
Tedroff
J
J
Department of Neuroscience, University Hospital, Uppsala, Sweden. joakim.tedroff@swipnet.se
Ekesbo
A
A
Sonesson
C
C
Waters
N
N
Carlsson
A
A
D018492:Dopamine Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy* / Q000503:physiopathology; D008875:Middle Aged; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
D018492:Dopamine Antagonists; D010880:Piperidines; C109513:OSU 6162